DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $78.41 which represents a slight increase of $0.69 or 0.89% from the prior close of $77.72. The stock opened at $78.09 and touched a low ...

DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), ...

Shares of DexCom Inc. DXCM inched 0.89% higher to $78.41 Monday, on what proved to be an all-around grim trading session for ...

In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

高估值背后，是Oura出色的商业化表现。根据前段时间公布的数据，Oura的智能戒指已经销售了250多万枚，今年的销量额将翻一番，达到5亿美金。而且，根据CEO Tom Hale的说法，Oura的利润率远高于传统硬件制造商，甚至接近软件公司。

Canaccord analyst William Plovanic raised the firm’s price target on DexCom (DXCM) to $99 from $89 and keeps a Buy rating on the shares.

“行业观察者”是我们针对人工智能、XR、元宇宙和Web3等前沿科技而设立的专栏，主要分享这些领域中的新兴企业或者创业者们的故事。智能戒指制造商Oura获得了美国连续血糖监测（CGM）巨头Dexcom领投的7500万美元融资，并建立战略合作伙伴关系，现 ...

The American Diabetes Association has released its annual guidelines and they now include continuous glucose monitor use for non-insulin use, ...

The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...

DexCom Inc (DXCM) stock saw a decline, ending the day at $78.92 which represents a decrease of $-2.09 or -2.58% from the prior close of $81.01. The stock opened at $80.91 and touched a low of $78.06 ...

Oura has become incredibly popular in the last few years. The company, originally from Finland, launched its first wearable ...